Expression and recruitment of uracil-DNA glycosylase are regulated by E2A during antibody diversification

Molecular Immunology

Volumn 60, Issue 1, 2014, Pages 23-31

  Wallenius, Anders ^a,b   Hauser, Jannek ^b   Aas, Per Arne ^a   Sarno, Antonio ^a   Kavli, Bodil ^a   Krokan, Hans E ^a   Grundström, Thomas ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Antibodies; B cells; Cell differentiation; Gene regulation; Transcription factors

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CALCIUM ION; CALMODULIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN HEAVY CHAIN; MESSENGER RNA; MYC PROTEIN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR E2A; URACIL; URACIL DNA GLYCOSIDASE;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA REPAIR; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES; B CELLS; CELL DIFFERENTIATION; GENE REGULATION; TRANSCRIPTION FACTORS;

ANIMALS; B-LYMPHOCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CALMODULIN; CELLS, CULTURED; CYTIDINE DEAMINASE; DNA REPAIR; DNA-BINDING PROTEINS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN HEAVY CHAINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; URACIL-DNA GLYCOSIDASE;

EID: 84898920232     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.03.011     Document Type: Article

References (52)

1. Aas P.A., Pena-Diaz J., Liabakk N.B., Krokan H.E., Skorpen F. Overexpression of transcription factor AP-2 stimulates the PA promoter of the human uracil-DNA glycosylase (UNG) gene through a mechanism involving derepression. DNA Repair (Amst) 2009, 8:822-833.
2. Andersen S., Ericsson M., Dai H.Y., Pena-Diaz J., Slupphaug G., Nilsen H., Aarset H., Krokan H.E. Monoclonal B-cell hyperplasia and leukocyte imbalance precede development of B-cell malignancies in uracil-DNA glycosylase deficient mice. DNA Repair (Amst) 2005, 4:1432-1441.
3. Bain G., Maandag E.C., Izon D.J., Amsen D., Kruisbeek A.M., Weintraub B.C., Krop I., Schlissel M.S., Feeney A.J., van Roon M., et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 1994, 79:885-892.
4. Beck K., Peak M.M., Ota T., Nemazee D., Murre C. Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci. J. Exp. Med. 2009, 206:2271-2284.
5. Bransteitter R., Pham P., Scharff M.D., Goodman M.F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4102-4107.
6. Conlon T.M., Meyer K.B. The chicken Ig light chain 3'-enhancer is essential for gene expression and regulates gene conversion via the transcription factor E2A. Eur. J. Immunol. 2006, 36:139-148.
7. Corneliussen B., Holm M., Waltersson Y., Onions J., Hallberg B., Thornell A., Grundström T. Calcium/calmodulin inhibition of basic-helix-loop-helix transcription factor domains. Nature 1994, 368:760-764.
8. Dedeoglu F., Horwitz B., Chaudhuri J., Alt F.W., Geha R.S. Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB. Int. Immunol. 2004, 16:395-404.
9. Di Noia J.M., Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 2007, 76:1-22.
10. Dickerson S.K., Market E., Besmer E., Papavasiliou F.N. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 2003, 197:1291-1296.
11. Doseth B., Visnes T., Wallenius A., Ericsson I., Sarno A., Pettersen H.S., Flatberg A., Catterall T., Slupphaug G., Krokan H.E., Kavli B. Uracil-DNA glycosylase in base excision repair and adaptive immunity: species differences between man and mouse. J. Biol. Chem. 2011, 286:16669-16680.
12. Gonda H., Sugai M., Nambu Y., Katakai T., Agata Y., Mori K.J., Yokota Y., Shimizu A. The balance between Pax5 and Id2 activities is the key to AID gene expression. J. Exp. Med. 2003, 198:1427-1437.
13. Greenbaum S., Zhuang Y. Identification of E2A target genes in B lymphocyte development by using a gene tagging-based chromatin immunoprecipitation system. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15030-15035.
14. Hagen L., Kavli B., Sousa M.M., Torseth K., Liabakk N.B., Sundheim O., Pena-Diaz J., Otterlei M., Horning O., Jensen O.N., Krokan H.E., Slupphaug G. Cell cycle-specific UNG2 phosphorylations regulate protein turnover, activity and association with RPA. EMBO J. 2008, 27:51-61.
15. Haug T., Skorpen F., Aas P.A., Malm V., Skjelbred C., Krokan H.E. Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase. Nucleic Acids Res. 1998, 26:1449-1457.
16. Hauser J., Grundström C., Grundström T. Allelic Exclusion of IgH through Inhibition of E2A in a VDJ Recombination Complex. J. Immunol. 2014, 192:2460-2470.
17. Hauser J., Sveshnikova N., Wallenius A., Baradaran S., Saarikettu J., Grundström T. B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1267-1272.
18. Hauser J., Verma-Gaur J., Wallenius A., Grundström T. Initiation of antigen receptor-dependent differentiation into plasma cells by calmodulin inhibition of E2A. J. Immunol. 2009, 183:1179-1187.
19. Hauser J., Wallenius A., Sveshnikova N., Saarikettu J., Grundström T. Calmodulin inhibition of E2A stops expression of surrogate light chains of the pre-B-cell receptor and CD19. Mol. Immunol. 2010, 47:1031-1038.
20. Hodgkin P.D., Lee J.H., Lyons A.B. B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 1996, 184:277-281.
21. Imai K., Slupphaug G., Lee W.I., Revy P., Nonoyama S., Catalan N., Yel L., Forveille M., Kavli B., Krokan H.E., Ochs H.D., Fischer A., Durandy A. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 2003, 4:1023-1028.
22. Kavli B., Andersen S., Otterlei M., Liabakk N.B., Imai K., Fischer A., Durandy A., Krokan H.E., Slupphaug G. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil. J. Exp. Med. 2005, 201:2011-2021.
23. -/- mice. Nucleic Acids Res. 2012, 40:6016-6025.
24. Langlands K., Yin X., Anand G., Prochownik E.V. Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. J. Biol. Chem. 1997, 272:19785-19793.
25. Lazorchak A., Jones M.E., Zhuang Y. New insights into E-protein function in lymphocyte development. Trends Immunol. 2005, 26:334-338.
26. Liu M., Duke J.L., Richter D.J., Vinuesa C.G., Goodnow C.C., Kleinstein S.H., Schatz D.G. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008, 451:841-845.
27. Maul R.W., Saribasak H., Martomo S.A., McClure R.L., Yang W., Vaisman A., Gramlich H.S., Schatz D.G., Woodgate R., Wilson D.M., Gearhart P.J. Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. Nat. Immunol. 2011, 12:70-76.
28. Michael N., Shen H.M., Longerich S., Kim N., Longacre A., Storb U. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 2003, 19:235-242.
29. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
30. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 1999, 274:18470-18476.
31. Murre C. Regulation and function of the E2A proteins in B cell development. Adv. Exp. Med. Biol. 2007, 596:1-7.
32. Nilsen H., Otterlei M., Haug T., Solum K., Nagelhus T.A., Skorpen F., Krokan H.E. Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res. 1997, 25:750-755.
33. Nilsen H., Rosewell I., Robins P., Skjelbred C.F., Andersen S., Slupphaug G., Daly G., Krokan H.E., Lindahl T., Barnes D.E. Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication. Mol. Cell 2000, 5:1059-1065.
34. Nilsen H., Stamp G., Andersen S., Hrivnak G., Krokan H.E., Lindahl T., Barnes D.E. Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene 2003, 22:5381-5386.
35. Pan L., Sato S., Frederick J.P., Sun X.H., Zhuang Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell. Biol. 1999, 19:5969-5980.
36. Pena-Diaz J., Jiricny J. Mammalian mismatch repair: error-free or error-prone?. Trends Biochem. Sci. 2012, 37:206-214.
37. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T., Neuberger M.S. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 2002, 12:1748-1755.
38. Rajagopal D., Maul R.W., Ghosh A., Chakraborty T., Khamlichi A.A., Sen R., Gearhart P.J. Immunoglobulin switch mu sequence causes RNA polymerase II accumulation and reduces dA hypermutation. J. Exp. Med. 2009, 206:1237-1244.
39. Saarikettu J., Sveshnikova N., Grundström T. Calcium/calmodulin inhibition of transcriptional activity of E-proteins by prevention of their binding to DNA. J. Biol. Chem. 2004, 279:41004-41011.
40. Saribasak H., Gearhart P.J. Does DNA repair occur during somatic hypermutation?. Semin. Immunol. 2012, 24:287-292.
41. Sayegh C.E., Quong M.W., Agata Y., Murre C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 2003, 4:586-593.
42. Schoetz U., Cervelli M., Wang Y.D., Fiedler P., Buerstedde J.M. E2A expression stimulates Ig hypermutation. J. Immunol. 2006, 177:395-400.
43. Schrader C.E., Guikema J.E., Linehan E.K., Selsing E., Stavnezer J. Activation-induced cytidine deaminase-dependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. J. Immunol. 2007, 179:6064-6071.
44. Sharbeen G., Yee C.W., Smith A.L., Jolly C.J. Ectopic restriction of DNA repair reveals that UNG2 excises AID-induced uracils predominantly or exclusively during G1 phase. J. Exp. Med. 2012, 209:965-974.
45. -/-) double-knockout mice. J. Immunol. 2006, 177:5386-5392.
46. Slupphaug G., Eftedal I., Kavli B., Bharati S., Helle N.M., Haug T., Levine D.W., Krokan H.E. Properties of a recombinant human uracil-DNA glycosylase from the UNG gene and evidence that UNG encodes the major uracil-DNA glycosylase. Biochemistry 1995, 34:128-138.
47. Stavnezer J., Björkman A., Du L., Cagigi A., Pan-Hammarström Q. Mapping of switch recombination junctions, a tool for studying DNA repair pathways during immunoglobulin class switching. Adv. Immunol. 2010, 108:45-109.
48. Tanaka A., Shen H.M., Ratnam S., Kodgire P., Storb U. Attracting AID to targets of somatic hypermutation. J. Exp. Med. 2010, 207:405-415.
49. Tran T.H., Nakata M., Suzuki K., Begum N.A., Shinkura R., Fagarasan S., Honjo T., Nagaoka H. B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol. 2010, 11:148-154.
50. -/- mice. J. Exp. Med. 2006, 203:2085-2094.
51. Yabuki M., Ordinario E.C., Cummings W.J., Fujii M.M., Maizels N. E2A acts in cis in G1 phase of cell cycle to promote Ig gene diversification. J. Immunol. 2009, 182:408-415.
52. Zhuang Y., Soriano P., Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell 1994, 79:875-884.